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Abstract 
Antimicrobial resistance has become an important con-
cern in veterinary medicine. The aim of this study was 
to describe the rate of antimicrobial resistance in com-
mon equine pathogens and to determine the occurrence 
of multidrug-resistant isolates. A retrospective analysis 
of all susceptibility testing results from bacterial patho-
gens cultured from horses at the University of Zurich 
Equine Hospital (2012–2015) was performed. Strains 
exhibiting resistance to 3 or more antimicrobial catego-
ries were defined as multidrug-resistant. Susceptibility 
results from 303 bacterial pathogens were analyzed, 
most commonly Escherichia coli (60/303, 20%) and 
Staphylococcus aureus (40/303, 13%). High rates of 
acquired resistance against commonly used anti-
microbials were found in most of the frequently isolated 
equine pathogens. The highest rate of multidrug resis-
tance was found in isolates of Acinetobacter baumannii 
(23/24, 96%), followed by Enterobacter cloacae complex 
(24/28, 86%) and Escherichia coli (48/60, 80%). Overall, 
60% of Escherichia coli isolates were phenotypically 
ESBL-producing and 68% of Staphylococcus spp. were 
phenotypically methicillin-resistant. High rates of 
acquired antimicrobial resistance towards commonly 
used antibiotics are concerning and underline the im-
portance of individual bacteriological and anti microbial 
susceptibility testing to guide antimicrobial therapy. 
Minimizing and optimizing antimicrobial therapy in 
horses is needed.
Keywords: horse, multidrug-resistant (MDR) bacteria, 
methicillin-resistant staphylococci (MRS), ESBL-producing 
Enterobacteriaceae, infection
Retrospektive Auswertung der  
Resistenzsituation bakterieller  
Pathogene bei hospitalisierten  
Pferden (2012–2015) 
Antibiotikaresistenzen gehören zu den grössten Heraus-
forderungen in der Tiermedizin unserer Zeit. Das Ziel 
dieser Studie war es, die Resistenzsituation der häufigs-
ten bakteriellen Pathogene und das Vorkommen von 
multiresistenten Keimen zu untersuchen. Es wurde eine 
retrospektive Analyse aller Empfindlichkeitsprüfungen 
von bakteriellen Pathogenen von Pferden am Tierspital 
Zürich (2012–2015) durchgeführt. Isolate welche Resis-
tenzen gegen 3 oder mehr Antibiotikaklassen zeigten, 
wurden als multiresistent definiert. Insgesamt wurden 
die Resultate von 303 Resistenzprüfungen ausgewertet, 
wobei am häufigsten Ergebnisse für Escherichia coli 
(60/303, 20%) und Staphylococcus aureus (40/303, 13%) 
vorlagen. Die grosse Mehrzahl der von Pferden isolier-
ten Infektionserreger zeigten hohe Resistenzraten gegen-
über gebräuchlichen Antibiotika, wobei Acinetobacter 
baumannii (23/24, 96%), gefolgt von Enterobacter cloacae 
complex Isolaten (24/28, 86%) und Escherichia coli 
(48/60, 80%) die höchsten Raten an Multiresistenz auf-
wiesen. Zusätzlich waren 60% der Escherichia coli 
Isolate phänotypisch ESBL-produzierend und 68% der 
Staphylokokken phänotypisch methicillin-resistent. Die 
hohen Resistenzraten gegenüber gebräuchlichen Anti-
biotika sind beunruhigend und unterstreichen die Wich-
tigkeit einer Kultur mit Empfindlichkeitsprüfung des 
Infek tionserregers, um eine gezielte Therapie einleiten 
zu können. Minimierung und Optimierung des Anti-
biotikaeinsatzes beim Pferd sind von grösster Wichtig-
keit. 
Schlüsselwörter: Pferd, multiresistente Bakterien,  
Methi cillin-resistente Staphylokokken (MRS), ESBL-produ-
zierende Enterobacteriaceae, Infektion
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Introduction 
Over the last decades, acquired antimicrobial resistance 
has gained increasing importance in human and veter-
inary medicine (WHO, 2011; Weese et al., 2015). 
Highly resistant bacterial isolates increase morbidity, 
mortality and costs of treatment for horses by increasing 
the risk of inappropriate and delayed antimicrobial ther-
apy (Weese et al., 2015). In addition, equine multi- 
resistant bacteria pose a public health concern, as trans-
mission of resistant isolates via human-horse contact 
and transmission of resistance genes between human 
and animal isolates has been shown (van Duijkeren et 
al., 2010; Dolejska et al., 2011). 
Methicillin-resistant staphylococci (MRS) and extended- 
spectrum b-lactamases (ESBL)- producing Enterobacte­
riaceae are currently the most important multidrug-re-
sistant (MDR) isolates in equine medicine (Maddox et 
al., 2015). Both acquired resistance towards b-lactam 
antibiotics, the most important antimicrobial category 
in veterinary medicine, and therefore substantially com-
plicate antimicrobial therapy (Weese, 2009). Methicillin 
resistance in Staphylococcus (S.) spp. is conferred by the 
mec gene. It encodes an altered penicillin-binding pro-
tein, rendering virtually all b-lactam antimicrobials used 
in veterinary medicine ineffective (Poole, 2004). Staphy-
lococci, including their methicillin-resistant subpopu-
lations, are part of the commensal equine flora. Methi-
cillin-resistant S. aureus (MRSA) have been isolated from 
the nares of up to 40% of hospitalized horses (Van den 
Eede et al., 2012) and methicillin-resistant coagulase- 
negative staphylococci (MR-CNS) from up to 80% of 
healthy horses (Corrente et al., 2009; Moodley and 
Guardabassi, 2009). Such previous colonization was 
identified as risk factor for the development of subse-
quent clinical disease with MRS (Weese et al., 2006). 
Common infections caused by these opportunistic path-
ogens include soft tissue, musculoskeletal and infections 
(Corrente et al., 2009; Maddox et al., 2010; van Spijk et 
al., 2016 accepted). Production of ESBL in Enterobacte­
riaceae allows the isolate to open the b-lactam ring of 
cephalosporins, thereby inactivating them (Paterson and 
Bonomo, 2005). While infections with ESBL-producing 
Enterobacteriaceae are well described in humans (Paterson 
and Bonomo, 2005), only small numbers of ESBL-pro-
ducing bacteria (mainly Escherichia (E.) coli) have so far 
been isolated from horses causing wound infections, 
arthritis and sepsis in foals (Dolejska et al., 2011; Dierikx 
et al., 2012; Smet et al., 2012; Walther et al., 2014). 
Additional bacteria of increasing concern are MDR 
Acinetobacter (A.) baumannii, Enterococcus spp. and 
Pseudomonas (P.) aeruginosa. Their high level of intrinsic 
resistance together with their ability to acquire resist-
ance towards a wide range of antimicrobial agents have 
led to their emergence as important pathogens in human 
medicine (Weese, 2009). Little is known about the role 
these highly resistant isolates play in equine infections 
(Maddox et al., 2015).
There are numerous studies from different countries 
describing antimicrobial resistance in equine pathogens 
(Clark et al., 2008; Theelen et al., 2014; Toombs-Ruane 
et al., 2015). Results from these studies aid practitioners 
in making an evidence based antimicrobial drug choice 
in cases where prompt therapy is needed and culture and 
susceptibility testing results cannot be awaited. Bacteri-
al resistance profiles can vary between geographical 
locations and change rapidly over time (Canton et al., 
2008). Therefore, continuous local surveillance is of 
great importance. Currently, there are very few data on 
antimicrobial resistance and the occurrence of multi-
drug resistance in equine pathogens in Switzerland 
(Panchaud et al., 2010). The objectives of this study were 
to retrospectively describe the rate of resistance to clin-
ically used antimicrobial drugs in pathogens isolated 
from horses and to analyze the occurrence of MDR 
isolates in horses presented to the Equine Hospital of 
the University of Zurich between 2012 and 2015. 
Material and Methods 
Data collection
The database of the Institute of Veterinary Bacteriology 
and the Equine Hospital of the University of Zurich 
were retrospectively analyzed for susceptibility testing 
results from bacterial pathogens cultured from horses 
presented to the Equine Hospital between March 2012 
and October 2015. Date of collection, origin of sample, 
diagnosis, cultured bacteria and susceptibility testing 
results were recorded. 
Classification 
Diagnoses were classified into 7 groups based on the 
origin of the sample. Implant infections, infections of 
incisions, injection sites and after dental procedures 
were grouped as post-procedural infections. Synovial 
infections, osteitis and hoof abscesses were combined 
to musculoskeletal infections. Soft tissue infections in-
cluded external abscesses, wounds, cellulitis and infect-
ed hematomas. Urinary tract infections contained upper 
and lower urinary tract infections and omphalitis. Res-
piratory tract infections included pathogens isolated 
from the upper and lower airways. Isolates from the 
uterus and from milk were summarized as reproductive 
infections. The rest of the samples was classified as 
‘diverse’ and included isolates from sepsis, dental infec-
tions, peritonitis, dermatitis, otitis, neoplasia infections 
and hepatitis. Bacteria isolated from fecal samples were 
excluded. Isolates considered non-pathogenic or con-
tamination were excluded based on information on 
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bacterial species, origin of sample, quantity of growth, 
the occurrence of mixed cultures and clinical findings. 
If opportunistic pathogens were isolated, they were only 
included if a role as causative pathogen seemed reason-
able based on clinical findings. When mixed infections 
occurred in one sample, all isolates were included. When 
a bacterial strain was isolated more than once within 
6 months from the same site in a horse, the isolate was 
considered to come from a persistent infection and was 
only counted once in the study.
Table 1: Antimicrobial categories and agents analyzed for defining multidrug resistance in A. baumannii, Enterobacteriaceae, Entero coccus spp.,  
P. aeruginosa and S. aureus. Table adapted from Magiorakos et al. (2012).
Bacteria Antimicrobial category Antimicrobial agents Notes
Acinteobacter  
baumannii
Aminoglycosides Gentamicin, Amikacin, Tobramycin
Extended-spectrum cephalosporins Cefpirom
Carbapenems Imipenem
Fluoroquinolones Enrofloxacin, Marbofloxacin
Folate pathway inhibitors Trimethoprim-sulphamethoxazole
Polymyxins Polymyxin B
Enterobacteriaceae* Aminoglycosides Gentamicin, Amikacin, Tobramycin
Penicillins Ampicillin E. cloacae and Klebsiella spp. intrinsically 
resistant
Carbapenems Imipenem
Extended-spectrum cephalosporins Cefpodoxim, Ceftiofur, Cefpirom
Fluoroquinolones Enrofloxacin, Marbofloxacin
Folate pathway inhibitors Trimethoprim-sulphamethoxazole
Non-extended spectrum cephalosporins Cefalexin E. cloacae intrinsically resistant
Penicillins + b-lactamase inhibitors Amoxicillin-clavulan acid E. cloacae intrinsically resistant
Phenicols Chloramphenicole
Polymyxins Polymyxin B Only tested in K. pneumoniae and E. coli
Tetracyclines Tetracycline
Enterococcus spp. Aminoglycosides Gentamicin (high level)
Penicillins Ampicillin
Carbapenems Imipenem Enterococcus faecium intrinsically resistant
Fluoroquinolones Enrofloxacin, Marbofloxacin
Glycopeptides Vancomycin
Tetracyclines Tetracyclin
Pseudomonas  
aeruginosa
Aminoglycosides Gentamicin, Amikacin, Tobramycin
Antipseudomonal cephalosporins Cefpirom
Antipseudomonal carbapenems Imipenem
Antipseudomonal fluoroquinolones Enrofloxacin, Marbofloxacin
Polymyxins Polymyxin B
Staphylococcus  
aureus
Aminoglycosides Gentamicin
Ansamycins Rifampicin
Antistaphylococcal b-lactams Oxacillin, Cefoxitin Resistance to either of these predicts MRSA 
phenotype (non-susceptibility to all cate-
gories of b-lactam antimicrobials, except of 
anti-MRSA cephalosporins) 
Fluoroquinolones Enrofloxacin, Marbofloxacin
Folate pathway inhibitors Trimethoprim-sulphamethoxazole
Fucidanes Fusidic acid
Glycopeptides Vancomycin
Lincosamides Clindamycin
Macrolides Erythromycin
Phenicols Chloramphenicol
Tetracyclines Tetracycline
* Enterobacteriaceae include: Enterobacter cloacae complex, E. coli, K. pneumoniae ssp. pneumoniae and Proteus mirabilis
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Culture and susceptibility testing
Depending on the isolation site, samples were streaked 
on standard agars (Columbia blood agar with sheep 
blood, Gassner agar, Columbia CNA agar, Chocolate 
agar with vitox, Oxoid AG, Pratteln, Switzerland) and 
incubated at 37 °C for 24–48 hours under aerobic con-
ditions. For culture of obligate anaerobes, samples were 
streaked on Columbia blood agar with sheep blood and 
Schaedler KV agar (Oxoid AG, Pratteln, Switzerland) 
and incubated at 37 °C under anaerobic conditions for 
48–72 hours. The samples were investigated by standard 
bacteriological methods using gram staining, catalase 
test, oxidase test, oxidation-fermentation test, aggluti-
nation test to check coagulase activity, agglutination test 
to classify the Lancefield groups of Streptococcus spp., 
Staphaurex® plus latex agglutination test (Oxoid AG, 
Pratteln, Switzerland) and growth performance on dif-
ferent agar (Markey, 2013).  Identification to species 
level and antimicrobial susceptibility testing for aerobic 
bacteria (microdilution method) was conducted using 
the automated VITEK® 2 Compact system (bioMérieux, 
Marcy l’Etoile, France) according to the manufacturer’s 
instructions. The AST-ST01 susceptibility testing card 
was used for Streptococcus spp., the AST-GP69 suscepti-
bility testing card for all other Gram-positive isolates 
and the AST-GN38 card for Gram-negative isolates. The 
advanced expert system (AES) of the VITEK® 2 provid-
ed minimal inhibitory concentration (MIC) and suscep-
tibility interpretations, which were automatically edited 
in some phenotypes (Livermore et al., 2002). Interpre-
tation of results referred to the guidelines from the Clin-
ical and Laboratory Standards Institute (CLSI, 2013) 
and, if information was lacking, guidelines from the 
European Committee on antimicrobial susceptibility 
testing (EUCAST, 2016) and the U.S. Food and Drug 
Administration (FDA, 2016) were used. Intermediate 
susceptibility was classified as resistant. 
ESBL production was evaluated phenotypically 
(pESBL-producing) in E. coli and Klebsiella (K.) pneumo­
niae ssp. pneumoniae by using the VITEK® 2 ESBL-screen 
test on the AST-GN38 card, assessing the inhibitory 
effect of cefotaxime, ceftazidime, and cefepime with 
and without clavulanic acid (Paterson and Bonomo, 
2005). The VITEK® 2 cefoxitin-screen test on the AST-
GP69 card was used to detect phenotypically methicillin- 
resistant (pMR) staphylococci ( John et al., 2009). 
Resistance to cefoxitin (6 µg/ml) indicated resistance to 
all b-lactam antibiotics (CLSI, 2013). 
MDR definition
Intrinsic resistance was adopted according to current 
knowledge (Hollenbeck and Rice, 2012; Leclercq et al., 
2013). MDR isolates were defined as isolates with ac-
quired resistance towards ≥1 agent in ≥3 defined anti-
microbial categories, according to an international ex-
pert proposal for MDR bacteria in human medicine 
(Magiorakos et al., 2012). If the antimicrobial category 
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Figure 1: Overview of number and origin of bacterial isolates with antimicrobial testing results from horses at the University of Zurich (2012–2015) 
Abbreviations: E. cloacae – Enterobacter cloacae complex, S. zooepidemicus – Streptococcus equi ssp. zooepidemicus, K. pneumoniae –  
Klebsiella pneumoniae ssp. pneumoniae
Others include: Citrobacter spp. (n=6), Pasteurella spp. (n=3), Proteus vulgaris group (n=2), Pantoea agglomerans (n=2), Streptococcus uberis 
(n=2), Streptococcus equinus (n=1), Bordetella bronchiseptica (n=1), Streptococcus equi ssp. equi (n=1), Streptococcus dysgalactiae ssp. equisi­
milis (n=1)
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was not evaluated in this study (e.g. glycylcyclines), it 
was not taken into account for definition of MDR iso-
lates. If available, commonly used equine antimicrobials 
were used for interpretation, instead of human antimi-
crobials (e.g. enrofloxacin instead of ciprofloxacin). The 
complete list of analyzed antimicrobials can be found 
in Table 1. This approach allowed determination of mul-
tidrug resistance prevalence in A. baumannii, E. coli, 
Enterobacter cloacae complex, K. pneumoniae ssp. 
pneumoniae, Proteus mirabilis, P. aeruginosa, Enterococcus 
spp. and S. aureus. 
Results 
The database included 303 susceptibility testing results 
from equine pathogens: 53/303 (17%) from 2012, 107/303 
(35%) from 2013, 83/303 (27%) from 2014, and 60/303 
(20%) from 2015. Most results were available for E. coli 
(60/303, 20%) and S. aureus (40/303, 13%), followed by 
Enterococcus (E.) spp. (containing E. faecalis and E. faecium) 
and coagulase-negative staphylococci (CNS) (each 
38/303, 13%). Most isolates were sampled from post-pro-
cedural (108/303, 36%), musculoskeletal (54/303, 18%), 
and soft tissue infections (37/303, 12%). An overview of 
bacterial isolates and their origin is shown in Figure 1. 
Resistance rates against common antimicrobials for bac-
teria with at least 7 isolates tested for antimicrobial sus-
ceptibility are shown in Table 2. High rates of acquired 
antimicrobial resistance were found in Gram-negative 
isolates. Amikacin was the only effective drug inhibiting 
growth of all Gram-negatives. Marbofloxacin resistance 
was rare in Gram-negative isolates, except for A. bauman­
nii. A. baumannii generally showed high resistance rates 
and the highest multidrug resistance prevalence of all 
bacteria (23/24, 96%). Enterobacter cloacae complex iso-
lates and E. coli also had high multidrug resistance rates 
of 86% (n=24/28) and 80% (n=48/60), respectively. 
The ESBL screen test was positive in 36/60 (60%) E. coli. 
Minimal changes in this percentage were seen between 
years (55–67%). Only a small number of K. pneumoniae 
ssp. pneumoniae was tested and 3/7 (43%) were 
pESBL-producing; all of them isolated from post pro-
cedural infections. Prevalence of pESBL-producing 
E. coli and K. pneumoniae ssp. pneumoniae in different 
organ systems is shown in Figure 2. P. aeruginosa is in-
trinsically resistant towards a wide range of anti-
microbials, but resistance towards other drugs, with the 
exception of enrofloxacin, was moderate. 
In Gram-positive isolates, high resistance rates were 
found in Staphylococcus spp. and Enterococcus spp., while 
Streptococcus equi ssp. zooepidemicus showed low resistance 
rates towards most tested antimicrobials, especially to-
wards b-lactam antibiotics. Staphylococcus spp. had high 
resistance rates to penicillin, ampicillin, ampicillin/
sulbactam, cephalosporins and tetracycline. Rifampicin 
and chloramphenicol were effective in inhibiting growth 
in a high percentage of staphylococci. In addition, most 
S. aureus were susceptible towards erythromycin and 
fluorochinolons, while CNS were more commonly sus-
ceptible to gentamicin. Multidrug-resistance prevalence 
in S. aureus was 65% (n=26/40). The cefoxitin-screen 
test was positive for 53/78 (68%) tested Staphylococcus 
spp. CNS were more commonly pMR (27/38, 71%, 
50–75% during study period) than S. aureus (26/40, 
65%, 50–80% during study period). A disproportion-
ately high percentage of Staphylococcus spp. from 
post-procedural infections was pMR (14/15, 93% of 
CNS and 18/21, 86% of S. aureus). In Figure 2 occur-
rence of pMR staphylococci in different organ systems 
is presented. Enterococcus spp. are intrinsically resistant 
towards all cephalosporins, trimethoprim-sulfametho-
xazole (TMPS) and erythromycin. In addition, acquired 
resistance was common for fluoroquinolons and tetra-
cycline. Ampicillin and ampicillin/sulbactam, followed 
by chloramphenicol, were most effective against 
Enterococcus spp.
Table 2: Resistance rate towards common antimicrobials and prevalence of multidrug resistance in bacterial pathogens from horses at the University of 
Zurich (2012–2015)
Only bacterial species with at least 7 tested isolates are shown n.a. not assessed
* Cefotaxim and Ceftriaxone tested
Abbreviations: for bacteria see Figure 1; Amox/Clav – amoxicillin/clavulanic acid, Amp/Sulb – ampicillin/sulbactam, 1th Gen – first generation cephalo-
sporin, 3rd Gen – third generation cephalosporin, 4th Gen – fourth generation cephalosporin, TMPS – trimethoprim/sulfamethoxazole, Enroflox. –  
enrofloxacin, Marboflox. – marbofloxacin, Erythro. – erythromycin, Tetrac. – tetracyclin, Chloramph. – chloramphenicol, MDR – multidrug-resistant
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Discussion 
The results of this study show a high level of antimicro-
bial resistance in common bacterial pathogens and a 
high prevalence of MDR pathogens isolated from pa-
tients at the Equine Hospital of the University of Zurich. 
Production of b-lactamase enzymes is the major mech-
anism of b-lactam resistance in Enterobacteriaceae (Poole, 
2004). High prevalence rates (up to 100%) of ESBL-pro-
ducing E. coli in feces of hospitalized horses treated 
with extended-spectrum cephalosporins are present 
(Dolejska et al., 2011; Damborg et al., 2012). Few 
studies have reported isolation of ESBL-producing 
Enterobacteriaceae from equine infections such as infect-
ed wounds, septic arthritis and sepsis (Dolejska et al., 
2011; Dierikx et al., 2012; Smet et al., 2012; Walther et 
al., 2014). Resistance rates against 3rd or 4th generation 
cephalosporins in Enterobacteriaceae from clinical sam-
ples are 5–14% and an increase over time was noted 
(Clark et al., 2008; Dierikx et al., 2012; Theelen et al., 
2014). In our collection, the prevalence of pESBL-pro-
ducing E. coli and K. pneumoniae ssp. pneumoniae was 
60% and 43%, respectively.
In this study Staphylococcus spp. showed high resistance 
rates against b-lactam antimicrobials. Resistance to-
wards penicillin is frequent in equine isolates (Clark et 
al., 2008; Theelen et al., 2014), while resistance towards 
other b-lactams, especially cephalosporins, is rarely re-
ported (Clark et al., 2008; Theelen et al., 2014). Here, 
68% of staphylococci showed cephalosporin resistance 
due to methicillin resistance. Methicillin resistance pre-
cludes therapy with all b-lactam antimicrobials, includ-
ing all penicillins, cephalosporins and carbapenems 
(Poole, 2004). In previous equine studies MRSA preva-
lence was 25–37% (Cuny et al., 2006; van Duijkeren et 
al., 2010), but in our study it was 65% MRSA and 71% 
MR-CNS. An outbreak of infections with a MDR 
S. aureus as reported in another hospital (Panchaud et 
al., 2010) did not occur and isolation rate remained sta-
ble between 2012 and 2015. Possible reasons for the 
increased prevalence include population and environ-
mental factors, antimicrobial treatment practices and 
diagnostic methods. In another study an increase in 
prevalence of MRS was noted over time and therefore 
a higher occurrence can be expected in more recent 
data (van Duijkeren et al., 2010). Additionally, several 
staphylococcal species with different prevalence of 
methicillin resistance are included in the MR-CNS 
group (Becker et al., 2014). Members of this group are 
increasingly important opportunistic pathogens in 
human medicine (Becker et al., 2014), but there are 
few reports of equine infections (Trostle et al., 2001; 
Corrente et al., 2009). The increasing number of CNS 
in clinical samples at our hospital (van Spijk et al., 2016 
accepted) indicates that these species are potentially 
emerging in equine disease.  
Figure 2: Organ distribution of pESBL-producing E. coli and K. pneumoniae ssp. pneumoniae and pMR Staphylococcus spp. 
from horses at the University of Zurich (2012–2015). 
Abbreviations: for bacteria see Figure 1; pESBL-producing – phenotypically ESBL-producing, pMR – phenotypically methicil-
lin-resistant, pMS – phenotypically methicillin-susceptible
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Acinetobacter spp., especially A. baumannii, are oppor-
tunistic pathogens involved in various equine infections 
(Weese, 2009). In recent years, they gained attention 
because of their ability to acquire high rates of antimi-
crobial resistance and the occurrence of pan-resistant 
A. baumannii (Valencia et al., 2009; Weese, 2009). An 
increasing occurrence of Acinetobacter spp. from equine 
infections was recently shown in our hospital (van 
Spijk et al., 2016 accepted) and isolates showed very high 
resistance rates (96% MDR). Amikacin, enrofloxacin 
and imipenem are generally thought to remain effective 
(Weese, 2009). While fluorochinolons showed poor ef-
ficacy in our isolates, no amikacin resistance was ob-
served and only a single isolate was imipenem-resistant 
(data not shown). Only little is known about the clinical 
importance of MDR A. baumannii infections in horses. 
Together with case reports of horses with similar infec-
tions ( Jokisalo et al., 2010) and human literature, our 
results suggest that clinicians should be aware of this 
highly resistant pathogen, especially in hospitalized 
horses. 
An increase in resistant enterococci was recently found 
in foal sepsis isolates and cases of MDR Enterococcus 
spp. causing musculoskeletal infections have been 
reported (Herdan et al., 2012; Theelen et al., 2014). 
Ampicillin alone or in combination with sulbactam and 
chloramphenicol remain reasonable treatment options 
(Weese, 2009; Theelen et al., 2014). Low-level resistance 
towards penicillin and gentamicin is intrinsic to 
enterococci, but combinations of both drugs can remain 
effective (Weese, 2009; Hollenbeck and Rice, 2012). 
However, very high MICs for gentamicin, so-called high 
level gentamicin resistance, in 68% of our enterococci 
isolates precludes such a therapeutic approach (data not 
shown). Resistance towards vancomycin is of critical 
concern in Enterococcus spp. in human medicine (Giguère 
et al., 2013; Maddox et al., 2015). Fortunately, vancomy-
cin-resistant enterococci were not present in our samples 
(data not shown). 
Similarly to other studies, P. aeruginosa isolates showed 
low resistance towards gentamicin, amikacin, and mar-
bofloxacin, but high resistance rates towards enrofloxa-
cin (Clark et al., 2008; Theelen et al., 2014). The use of 
fluorchinolons in general should be minimized because 
of their classification as critically important drugs in 
human medicine (WHO, 2011). 
A low-level of antimicrobial resistance was seen in 
S. equi ssp. zooepidemicus isolates. In accordance to oth-
er studies, full susceptibility towards b-lactam antibiot-
ics was seen and they remain the most important drugs 
in treating infections caused by streptococci (Erol et al., 
2012; Theelen et al., 2014). In order to reduce the use 
of critically important antimicrobials for human medi-
cine (WHO, 2011), penicillin should be preferred to 
later-generation cephalosporins in these cases. Combi-
nations of penicillin with streptomycin are contraindi-
cated due to widespread resistance against streptomycin 
and its common side effects (Giguère et al., 2013).
A disproportionally high rate of pMR staphylococci 
(89%) was isolated from post-procedural infections, 
compared to 68% in staphylococci from all samples. 
MDR A. baumannii and pESBL-producing Entero­
bacteriaceae were other frequent pathogens from 
post-procedural infections. Factors like antimicrobial 
therapy, hospitalization, duration of therapy and hospi-
talization, as well as local or systemic immunosuppres-
sion favor the development of resistant isolates in these 
infections (Struelens, 1998). Bacteriological culture and 
susceptibility testing are particularly important to guide 
antimicrobial therapy in these cases.
The high resistance rates against commonly used anti-
microbials found in this study, would suggest a high 
percentage of prophylactic and therapeutic treatment 
failure. However, prevalence of post-operative infections 
at our hospital is comparable to other studies, e.g. con-
firmed bacterial incisional infections occurred in 7.4% 
of colic surgeries (data not shown) compared to 9.3% in 
other studies (Torfs et al., 2010). Furthermore, the gen-
eral clinical perception at our hospital is that bacterial 
infections, other than sepsis, are not generally associat-
ed with a high mortality rate, although outcome was not 
specifically analyzed in this study. Results of the present 
study show that antimicrobial therapy is frequently in-
effective and likely unnecessary as no increase in ther-
apy failure seemed to occur. Depending on the affected 
organ, additional therapy such as local therapy is con-
sidered to be of major importance to successfully treat 
bacterial infections. 
Caution needs to be applied when comparing to results 
from older studies, which mainly used formerly com-
mon disc diffusion testing methods and out-dated CLSI 
guidelines. In this study only samples from hospitalized 
horses were included and extrapolation of results to the 
field is difficult. Our hospital population is frequently 
treated with antimicrobials prior to referral and samples 
from complicated cases might be overrepresented. How-
ever, primary cases were also included. Definition of 
MDR isolates is inconsistent in medical literature, pre-
cluding reliable comparison of data. In order to reach a 
standardized definition, we implemented the multidrug 
resistance definition from human medicine (Magiorakos 
et al., 2012). This adaption was limited by unavailabil-
ity of certain susceptibility results and differing antimi-
crobial agents in human and veterinary medicine. 
Therefore, establishment of a standard definition of 
MDR bacteria in veterinary medicine should be sup-
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ported. Identification of ESBL-producing Entero­
bacteriaceae and MRS was limited to phenotypical 
analysis. Genotypic analysis is not common for routine 
clinical diagnostics, but would allow confirmation of 
results and provide epidemiological information. 
Conclusion 
In conclusion, high levels of resistance in equine path-
ogens were present, complicating therapy with common-
ly used antimicrobial agents, like penicillins, cephalo-
sporins, gentamicin or TMPS. This underlines the 
importance of individual bacteriological and anti-
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microbial susceptibility testing as well as minimizing 
and optimizing the antimicrobial therapy in horses to 
reduce further development of resistance. 
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Valutazione retrospettiva della  
prevalenza della resistenza ai batteri 
patogeni nei cavalli ricoverati  
(2012–2015) 
La resistenza agli antibiotici fa parte delle più grandi 
sfide nel campo della medicina veterinaria ai nostri gior-
ni. Lo scopo di questo studio era di valutare la preva-
lenza della resistenza dei batteri patogeni più comuni e 
la presenza di germi multi-resistenti. Un’analisi retro-
spettiva di tutti i test di sensibilità dei batteri patogeni 
nei cavalli è stata eseguita presso l’Ospedale veterinario 
di Zurigo (2012–2015). Gli isolati che mostrano resisten-
ze verso tre o più classi di antibiotici sono stati definiti 
come multi-resistenti. Complessivamente, sono stati 
valutati i risultati di 303 prove di resistenza, tra cui ri-
correvano di frequente Escherichia coli (60/303, 20%), e 
Staphylococcus aureus (40/303, 13%). La grande maggio-
ranza degli agenti infettivi isolati dei cavalli hanno mo-
strato alti tassi di resistenza agli antibiotici usati comu-
nemente, quali Acinetobacter baumannii (23/24, 96%), 
seguito da Enterobacter cloacae isolati complessi (24/28, 
86%) e Escherichia coli (48/60, 80 %) che ha ottenuto il 
più alto tasso di resistenza. Inoltre, il 60% degli isolati 
di Escherichia coli erano fenotipicamente produttori di 
ESBL e il 68% degli stafilococchi erano fenotipicamen-
te meticillino-resistenti. Gli alti tassi di resistenza agli 
antibiotici usati comunemente sono preoccupanti e 
sottolineano l’importanza di una cultura con test di 
sensibilità dell’agente infettivo, al fine di avviare una 
terapia mirata. La minimizzazione e l’ottimizzazione 
dell’uso di antibiotici nel cavallo sono della massima 
importanza. 
Analyse rétrospective des résistances 
rencontrées chez les bactéries  
pathogènes isolées sur des chevaux 
hospitalisés (2012–2015) 
Les résistances aux antibiotiques font partie des plus 
grands défis rencontrés par la médecine vétérinaire de 
notre temps. Le but de la présente étude était d’étudier 
la situation des résistances chez les bactéries pathogènes 
les plus communes ainsi que la survenance de germes 
multi-résistants. On a procédé à une analyse rétrospec-
tive de tous les tests de sensibilité effectués sur des 
germes pathogènes isolés sur des chevaux à l’Hôpital 
vétérinaire de Zürich entre 2012 et 2015. Les isolats pré-
sentant des résistances vis-à-vis de trois classes d’anti-
biotiques ou plus ont été définis comme multi-résistants. 
Au total on a exploité les résultats de 303 tests de sensi-
bilité, parmi lesquels on trouvait particulièrement des 
résultats concernant Escherichia coli (60/303, 20%) et 
Staphylococcus aureus (40/303, 13%). La grande majorité 
des germes pathogènes isolés sur des chevaux présen-
taient un taux de résistances élevé face aux antibiotiques 
usuels, Acinetobacter baumannii (23/24, 96%), suivi par 
des isolats complexes d’Enterobacter cloacae (24/28, 86%) 
et par Escherichia coli (48/60, 80%) montrant la plus 
haute proportion de résistances multiples. En outre, 
60% des isolats d’Escherichia coli étaient phénotypique-
ment producteurs d’ESBL et 68% des staphylocoques 
étaient phénotypiquement résistant à la méthicilline. 
Ces taux élevés de résistances vis-à-vis des antibiotiques 
usuels sont inquiétants et soulignent l’importance d’une 
culture avec test de sensibilité pour pouvoir mettre en 
œuvre un traitement ciblé. La réduction et l’optimisa-
tion de l’usage des antibiotiques chez le cheval sont 
d’une grande importance. 
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